Trial
NCT00903942
Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Rochester
Collaborators
Celgene Corporation
Condition
Non-small Cell Lung Cancer, Stage III
Intervention
radiation therapy
Why stopped
funding was withdrawn from Drug company
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-27